Implanatable cardiac stimulation device and method for prolonging atrial refractoriness

• US 6,377,852 B1
• Filed: 01/20/2000
• Issued: 04/23/2002
• Est. Priority Date: 01/20/2000
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Boileau, Peter, Florio, Joseph J., Bornzin, Gene A., Sloman, Laurence S.
• Primary Examiner(s): Getzow, Scott M.
• Application Number:
  US09/488,284
• Time in Patent Office: 824 Days
• Field of Search: 607/4, 607/5, 607/14, 607/9
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

An implantable cardiac stimulation device, e.g., a pacemaker or an implantable cardioverter defibrillator (ICD), is provided which prolongs the atrial refractoriness of a heart. The implantable cardiac stimulation device includes a generator that delivers pacing pulses to an atrium of a heart and a detector that detects atrial activations of the heart. An inhibitor is coupled to the detector that inhibits the generator when an atrial activation is detected within an escape interval. A generator control coupled to the generator causes the generator to deliver a primary pacing pulse to the atrium at the end of the escape interval, absent an atrial activation being detected within the escape interval, and causes the generator to deliver a secondary pacing pulse to the atrium a delay time after an atrial activation is detected within the escape interval or the delivery of a primary pacing pulse to the atrium.

Claims

1. An implantable cardiac stimulation device for stimulating a patient'"'"'s heart through a first electrode implanted in electrical contact with an atrium of the patient'"'"'s heart, the cardiac stimulation device comprising:

a first pulse generator adapted to be electrically coupled to the electrode and configured to generate stimulation pulses to thereby stimulate the patient'"'"'s heart; and

a controller coupled to the first pulse generator for causing the first pulse generator to deliver a secondary atrial pacing pulse to the atrium an atrial delay time after a primary atrial event, whereby the refractory period of the atrium is prolonged.

2. The implantable cardiac stimulation device of claim 1 further including an atrial detection circuit adapted to be coupled to the first electrode and configured to determine the presence of a P-wave as the primary atrial event wherein the secondary atrial pacing pulse is delivered a first determined atrial delay time after the P-wave.

3. The implantable cardiac stimulation device of claim 1 wherein the primary atrial event is the delivery of a primary atrial pacing pulse by the first pulse generator under control of the controller wherein the secondary atrial pacing pulse is delivered a second determined atrial delay time after the primary atrial pacing pulse.

4. The implantable cardiac stimulation device of claim 1 wherein the determined atrial delay time is between about 180 milliseconds and 300 milliseconds.

5. The implantable cardiac stimulation device of claim 1 wherein the cardiac stimulation device is additionally configured to stimulate a ventricle of the patient'"'"'s heart through a second electrode implanted in electrical contact with a ventricle of the patient'"'"'s heart, the cardiac stimulation device further including:

an AV delay timer that times an AV delay interval, wherein the AV delay timer is responsive to the primary atrial event, and

a second pulse generator responsive to the AV delay timer that provides a ventricular pacing pulse at the end of the AV delay interval.

6. The implantable cardiac stimulation device of claim 5 further including an atrial detection circuit adapted to be coupled to the first electrode and configured to determine the presence of a P-wave as the primary atrial event.

7. The implantable cardiac stimulation device of claim 5 wherein the primary atrial event is the delivery of a primary atrial pacing pulse by the first pulse generator under control of the controller.

8. The implantable cardiac stimulation device of claim 5, further comprising:

a ventricular detection circuit that detects ventricular events; and

whereby

the controller inhibits the second pulse generator when a ventricular event is detected during the AV delay interval.

9. The implantable cardiac stimulation device of claim 5 further including an atrial delay timer for timing the atrial delay time.

10. The implantable cardiac stimulation device of claim 5 wherein the atrial delay time is between about 180 milliseconds and 300 milliseconds.

11. The implantable cardiac stimulation device of claim 1 wherein the atrial delay timer is additionally configured to time an atrial escape interval following a ventricular event and wherein the first pulse generator is configured to deliver a primary atrial pacing pulse at the end of the atrial escape interval.

12. The implantable cardiac stimulation device of claim 1 wherein the primary atrial event includes detection of a P-wave and delivery of a primary atrial pacing pulse and the atrial delay time includes a first determined delay time following the detection of a P-wave and a second atrial delay time following delivery of a primary atrial pacing pulse.

13. The implantable cardiac stimulation device of claim 1 wherein the atrial delay time is periodically determined to prolong the refractory period of the atrium while avoiding stimulation of the ventricle of the patient'"'"'s heart resulting from the secondary atrial pacing pulse.

14. The implantable cardiac stimulation device of claim 1 wherein the delivery of the secondary atrial pacing pulse is limited to predefined time periods.

15. The implantable cardiac stimulation device of claim 14 wherein the predefined time periods include those time periods when the patient is at rest.

16. The implantable cardiac stimulation device of claim 14 wherein the predefined time periods include a period of time following detection of a high incidence of premature atrial contractions.

17. An implantable cardiac stimulation device comprising:

generating means for delivering pacing pulses to an atrium of a patient'"'"'s heart; and

control means coupled to the generating means for causing the generating means to deliver a primary pacing pulse to the atrium and causing the generating means to deliver a secondary pacing pulse to the atrium a delay time after the delivery of the primary pacing pulse.

18. The implantable cardiac stimulation device of claim 17 further including:

AV delay timing means for timing an AV delay interval responsive to the delivery of a primary pacing pulse; and

second generating means responsive to the AV delay timing means for providing a ventricular pacing pulse at the end of the AV delay interval.

19. The implantable cardiac stimulation device of claim 18 further including ventricular activation detecting means for detecting ventricular activations of the heart and ventricular inhibiting means for inhibiting the second generating means when a ventricular activation is detected during the AV delay interval.

20. The implantable cardiac stimulation device of claim 17 further including timing means for timing the delay time.

21. The implantable cardiac stimulation device of claim 20 wherein the delay time is between about 180 milliseconds and 300 milliseconds.

22. The implantable cardiac stimulation device of claim 17 further including detecting means for detecting atrial activations of the heart, wherein the control means includes inhibiting means for inhibiting the generator from providing the primary pacing pulse when an atrial activation is detected during an escape interval and wherein the control means further causes the generator to deliver the secondary pacing pulse to the atrium the delay time after an atrial activation is detected during the escape interval.

23. The implantable cardiac stimulation device of claim 22 further including a timing means for timing the delay time responsive to the delivery of a primary pacing pulse or the detection of an atrial activation during the escape interval.

24. The implantable cardiac stimulation device of claim 23 wherein the delay time is between about 180 milliseconds and 300 milliseconds.

25. The implantable cardiac stimulation device of claim 22 further including AV delay timing means for timing an AV delay interval responsive to the delivery of a primary pacing pulse or the detection of an atrial activation within the escape interval;

and

second generating means responsive to the AV delay timing means for providing a ventricular pacing pulse at the end of the AV delay interval.

26. The implantable cardiac stimulation device of claim 25 further including ventricular activation detecting means for detecting ventricular activations of the heart and ventricular inhibiting means for inhibiting the second generating means when a ventricular activation is detected during the AV delay interval.

27. The implantable cardiac stimulation device of claim 17 wherein the delivery of the secondary atrial pacing pulse is limited to predefined time periods.

28. The implantable cardiac stimulation device of claim 27 wherein the predefined time periods include those time periods when the patient is at rest.

29. The implantable cardiac stimulation device of claim 27 wherein the predefined time periods include a period of time following detection of a high incidence of premature atrial contractions.

30. A method of pacing a patient'"'"'s heart, the method comprising the steps of:

determining a primary atrial event;

timing a delay time period following the primary atrial event; and

delivering a secondary atrial pacing pulse to an atrium of the patient'"'"'s heart at the end of the delay time period, whereby the refractory period of the atrium is prolonged.

31. The method of claim 30 wherein the delay time period is between about 180 milliseconds and 300 milliseconds.

32. The method of claim 30 additionally comprising the step of detecting the presence of a P-wave and designating the detected P-wave as the primary atrial event.

33. The method of claim 30 additionally comprising delivering a primary pacing pulse to the atrium of the patients heart, wherein the primary atrial pacing pulse is designated as the primary atrial event.

34. The method of claim 30 additionally comprising the step of timing an AV delay time period following the primary atrial event and delivering a ventricular pacing pulse to a ventricle of the patient'"'"'s heart at the end of the AV delay time period.

35. The method of claim 34 additionally comprising the step of detecting ventricular activations of the patient'"'"'s heart and inhibiting the delivery of the ventricular pacing pulse to the ventricle when a ventricular event is detected during the AV delay time period.

36. The method of claim 30 additionally comprising the steps of:

detecting atrial activations of the patient'"'"'s heart;

timing an atrial escape interval;

inhibiting the delivery of the primary atrial pacing pulse when an atrial activation is detected during the atrial escape interval; and

timing the delay time period upon detecting an atrial activation during the atrial escape interval.

37. The method of claim 30 additionally comprising the steps of:

setting the delay time period to a predetermined maximum value;

sensing, following the delivery of each secondary atrial pacing pulse, whether a ventricular depolarization occurred; and

decreasing the delay time period by a predetermined amount if a ventricular depolarization was sensed in response to the secondary atrial pacing pulse.

38. The method of claim 37 wherein the step of decreasing the delay time period is bypassed if the decreasing step would decrease the delay time below a predetermined minimum value.

39. The method of claim 37 wherein the step of setting the delay time period to a predetermined maximum value occurs periodically.

40. The method of claim 30 wherein the step of delivering the secondary atrial pacing pulse is limited to predefined time periods.

41. The method of claim 40 wherein the predefined time periods include those time periods when the patient is at rest.

42. The method of claim 40 wherein the predefined time periods include a period of time following detection of a high incidence of premature atrial contractions.

43. An implantable cardiac stimulation device for stimulating a patient'"'"'s heart through a first electrode in electrical communication with an atrium of the patient'"'"'s heart, the implantable stimulation device comprising:

a pulse generator adapted to be electrically coupled to the electrode and that is operative to generate pacing pulses for delivery to the atrium via the electrode; and

a controller that is coupled to the pulse generator and operative to cause the pulse generator to deliver a primary pacing pulse to the atrium and a secondary pacing pulse to the atrium a delay time after the delivery of the primary pacing pulse.

44. The implantable cardiac stimulation device of claim 43 wherein the delay time is at least about 120 milliseconds.

45. The implantable cardiac stimulation device of claim 44 wherein the delay time is between about 180 milliseconds and 300 milliseconds.

46. An implantable cardiac stimulation device for stimulating a patient'"'"'s heart through a first electrode in electrical communication with an atrium of the patient'"'"'s heart, the implantable stimulation device comprising:

sensing circuitry that senses cardiac activity;

a pulse generator adapted to be electrically coupled to the electrode and that is operative to generate pacing pulses for delivery to the atrium via the electrode; and

a controller that is coupled to the sensing circuitry and the pulse generator, wherein the controller is operative to receive sense signals from the sensing circuitry and to cause the pulse generator to deliver a secondary pacing pulse to the atrium at least about 120 milliseconds after a primary atrial event.

47. The implantable cardiac stimulation device of claim 46 wherein the atrial delay time is at least about 150 milliseconds.

48. The implantable cardiac stimulation device of claim 46 wherein the atrial delay time is between about 180 milliseconds and 300 milliseconds.

49. The implantable cardiac stimulation device of claim 46 wherein the primary atrial event is a primary pacing pulse, and wherein the controller is responsive to the detection of no intrinsic activity after an escape interval to control the pulse generator to deliver the primary pacing pulse.